Sulkshane · Redox biology 2021 · in vitro mechanistic study · n=?

Ubiquitination and receptor-mediated mitophagy converge to eliminate oxidation-damaged mitochondria during hypoxia.

Cited 183 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Bench research in cell culture models with no direct human clinical data.

PubMed 34175667 · doi:10.1016/j.redox.2021.102047 · record verified 2026-08-28

What was done

The authors investigated the pathway mediating mitochondrial degradation under hypoxia and chemical hypoxia (CoCl2) in cell models. They examined mitochondrial ubiquitination patterns and the role of the ubiquitin-proteasome system via proteasome inhibition and mitochondrial protein profiling (MFN1/2, TOM20). Using genetic ablation models, they tested the requirement of classical ubiquitin-binding receptors (p62, NDP52, Optineurin, NBR1, TAX1BP1), hypoxia-induced mitophagy receptors (BNIP3/NIX double knockouts), and mitochondrial fission machinery (DRP1-null cells). They also evaluated the effect of antioxidants (N-acetylcysteine and Mitoquinone) on HIF-1α stabilization and mitophagy induction.

What was found

Hypoxia and CoCl2 triggered Parkin-independent mitophagy accompanied by Lysine 48-linked ubiquitination and proteasomal degradation of MFN1/2 and TOM20. Proteasome inhibition blocked CoCl2-induced mitophagy. Five canonical ubiquitin-binding autophagy receptors were dispensable for mitochondrial clearance. Instead, mitochondrial elimination required DRP1-dependent fission and recruitment of the hypoxia-induced receptors BNIP3 and NIX. Treatment with N-acetylcysteine or Mitoquinone prevented HIF-1α stabilization, reduced mitochondrial oxidative stress, and suppressed mitophagy. No quantitative effect sizes or numerical values were reported in the abstract.

Why it matters

This study demonstrates that hypoxic mitophagy couples proteasomal degradation of outer-membrane proteins with receptor-mediated (BNIP3/NIX) autophagic engulfment independently of Parkin, clarifying how cells clear oxidative-damaged mitochondria under low oxygen.

Limits

All findings derive from in vitro cell line models without validation in primary human tissues or in vivo models. Specific cell types and baseline experimental parameters are not detailed in the abstract, and no quantitative data or statistical estimates are provided.

Cited by